Roka Attila, Borgquist Rasmus, Singh Jagmeet
Cardiology Division, Cardiac Arrhythmia Service, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA.
Cardiology Division, Cardiac Arrhythmia Service, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA.
Heart Fail Clin. 2017 Jan;13(1):79-91. doi: 10.1016/j.hfc.2016.07.007.
Although cardiac resynchronization therapy improves morbidity and mortality in patients with cardiomyopathy, heart failure, and electrical dyssynchrony, the rate of nonresponders using standard indications and implant techniques is still high. Optimal coronary sinus lead positioning is important to increase the chance of successful resynchronization. Patient factors such as cause of heart failure, type of dyssynchrony, scar burden, coronary sinus anatomy, and phrenic nerve capture may affect the efficacy of the therapy. Several modalities are under investigation. Alternative left ventricular lead implantation strategies are occasionally required when the transvenous route is not feasible or would result in a suboptimal lead position.
尽管心脏再同步治疗可改善心肌病、心力衰竭和电不同步患者的发病率和死亡率,但采用标准适应症和植入技术时无反应者的比例仍然很高。最佳冠状静脉窦导联定位对于增加成功再同步的机会很重要。诸如心力衰竭病因、不同步类型、瘢痕负荷、冠状静脉窦解剖结构和膈神经捕捉等患者因素可能会影响该治疗的疗效。有几种方式正在研究中。当经静脉途径不可行或会导致导联位置不理想时,偶尔需要采用替代的左心室导联植入策略。